Title:
N-ACETYLDIAMINOBUTYRIC ACID-CONTAINING COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2018/115475
Kind Code:
A3
Abstract:
The invention relates to a composition which contains N-acetyldiaminobutyric acid, a salt or an ester of N-acetyldiaminobutyric acid for use in a method for the treatment of the human or animal body.
Inventors:
BILSTEIN ANDREAS (DE)
Application Number:
PCT/EP2017/084454
Publication Date:
August 23, 2018
Filing Date:
December 22, 2017
Export Citation:
Assignee:
BITOP AG (DE)
International Classes:
A61K31/197; A61K8/44; A61P1/00; A61P11/06; A61P17/04; A61P17/06; A61Q17/04; A61Q19/00; A61Q19/08
Domestic Patent References:
| WO1993003714A2 | 1993-03-04 |
Other References:
RONQUIST G ET AL: "Antitumor activity of L-2,4 diaminobuturic acid against mouse fibrosarcoma cells in vitro and in vivo.", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 1980, vol. 96, no. 3, 1980, pages 259 - 268, XP009506043, ISSN: 0171-5216
CÁNOVAS D ET AL: "Role of Ngamma-acetyldiaminobutyrate as an enzyme stabilizer and an intermediate in the biosynthesis of hydroxyectoine", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 65, no. 9, 1 September 1999 (1999-09-01), pages 3774 - 3779, XP002253695, ISSN: 0099-2240
CÁNOVAS D ET AL: "Role of Ngamma-acetyldiaminobutyrate as an enzyme stabilizer and an intermediate in the biosynthesis of hydroxyectoine", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 65, no. 9, 1 September 1999 (1999-09-01), pages 3774 - 3779, XP002253695, ISSN: 0099-2240
Attorney, Agent or Firm:
SCHÖNEBORN, Holger et al. (DE)
Download PDF:
Previous Patent: ISOLATION OF A NOVEL PESTIVIRUS CAUSING CONGENITAL TREMOR A
Next Patent: SPECIFIC TLR4 ANTAGONIST IN THE TREATMENT OF MULTIPLE MYELOMA
Next Patent: SPECIFIC TLR4 ANTAGONIST IN THE TREATMENT OF MULTIPLE MYELOMA